Literature DB >> 19911124

APOBEC deaminases-mutases with defensive roles for immunity.

Courtney Prochnow1, Ronda Bransteitter, XiaoJiang S Chen.   

Abstract

In recent years, tremendous progress has been made in the elucidation of the biological roles and molecular mechanisms of the apolioprotein B mRNA-editing enzyme catalytic polypeptide (APOBEC) family of enzymes. The APOBEC family of cytidine deaminases has important functional roles within the adaptive and innate immune system. Activation induced cytidine deaminase (AID) plays a central role in the biochemical steps of somatic hypermutation and class switch recombination during antibody maturation, and the APOBEC 3 enzymes are able to inhibit the mobility of retroelements and the replication of retroviruses and DNA viruses, such as the human immunodeficiency virus type-1 and hepatitis B virus. Recent advances in structural and functional studies of the APOBEC enzymes provide new biochemical insights for how these enzymes carry out their biological roles. In this review, we provide an overview of these recent advances in the APOBEC field with a special emphasis on AID and APOBEC3G.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19911124     DOI: 10.1007/s11427-009-0133-1

Source DB:  PubMed          Journal:  Sci China C Life Sci        ISSN: 1006-9305


  13 in total

1.  Injury-dependent Müller glia and ganglion cell reprogramming during tissue regeneration requires Apobec2a and Apobec2b.

Authors:  Curtis Powell; Fairouz Elsaeidi; Daniel Goldman
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

2.  Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.

Authors:  Fumiaki Ito; Yang Fu; Shen-Chi A Kao; Hanjing Yang; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2017-05-04       Impact factor: 5.469

3.  The in vitro Biochemical Characterization of an HIV-1 Restriction Factor APOBEC3F: Importance of Loop 7 on Both CD1 and CD2 for DNA Binding and Deamination.

Authors:  Qihan Chen; Xiao Xiao; Aaron Wolfe; Xiaojiang S Chen
Journal:  J Mol Biol       Date:  2016-04-08       Impact factor: 5.469

4.  Effect of apolipoprotein B mRNA-editing catalytic polypeptide-like protein-3G in cervical cancer.

Authors:  Yanhua Xu; Junhong Leng; Fang Xue; Ruiqian Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants.

Authors:  Yunxiang Mu; Courtney Prochnow; Phuong Pham; Xiaojiang S Chen; Myron F Goodman
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

6.  RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase.

Authors:  Guoxin Liang; Kouichi Kitamura; Zhe Wang; Guangyan Liu; Sajeda Chowdhury; Weixin Fu; Miki Koura; Kousho Wakae; Tasuku Honjo; Masamichi Muramatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

7.  The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis.

Authors:  Kin Chan; Michael A Resnick; Dmitry A Gordenin
Journal:  DNA Repair (Amst)       Date:  2013-08-26

Review 8.  AID and Apobec3G haphazard deamination and mutational diversity.

Authors:  Malgorzata Jaszczur; Jeffrey G Bertram; Phuong Pham; Matthew D Scharff; Myron F Goodman
Journal:  Cell Mol Life Sci       Date:  2012-11-22       Impact factor: 9.261

9.  APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.

Authors:  Zhe Wang; Kousho Wakae; Kouichi Kitamura; Satoru Aoyama; Guangyan Liu; Miki Koura; Ahasan M Monjurul; Iwao Kukimoto; Masamichi Muramatsu
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

10.  LINE-1 retroelements complexed and inhibited by activation induced cytidine deaminase.

Authors:  Mirjam Metzner; Hans-Martin Jäck; Matthias Wabl
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.